Those tumors with HRD were all diagnosed as high grade serous carcinoma, specifically harboring fusions involving NRG1 and the JAG1, SPON1, and TNFRSF12A partner genes. The gene discussed is TNFRSF12A; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.